Rapid Stimulation of Bone Formation by Bortezomib in Multiple Myeloma

被引：0
|
作者：
Plesner, T. [1 ]
Lund, T.
Soe, K.
Abildgaard, N. [2 ]
Garnero, P.
Pedersen, P. T. [2 ]
Delaisse, J. M. [2 ]
机构：
[1] Vejle Hosp, Dept Hematol, Vejle, Denmark
[2] Odense Univ Hosp, Dept Hematol, Odense, Denmark
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70550-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [21] Bortezomib (Velcade) for multiple myeloma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1161): : 57 - 58
  • [22] Bortezomib treatment for multiple myeloma
    Stanford, BL
    Zondor, SD
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1825 - 1830
  • [23] Subcutaneous Bortezomib In Multiple Myeloma
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (01) : 45 - 54
  • [24] Bortezomib for the treatment of multiple myeloma
    Grosicki, Sebastian
    Barchnicka, Agnieszka
    Jurczyszyn, Artur
    Grosicka, Anida
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 173 - 185
  • [25] Quantitative in-Vivo Monitoring of Bone Formation in Multiple Myeloma Patients Following Treatment with Bortezomib: A Pilot Study
    Regelink, Josien C.
    Raijmakers, Pieter G.
    Bravenboer, Nathalie
    Hoetjes, Nikie
    Lips, Paul
    Zweegman, Sonja
    BLOOD, 2011, 118 (21) : 1268 - 1268
  • [26] Bortezomib directly inhibits osteoclast function in multiple myeloma: Implications into the management of myeloma bone disease
    Terpos, Evangelos
    LEUKEMIA RESEARCH, 2008, 32 (11) : 1646 - 1647
  • [27] Prospective evaluation of bone histomorphometric changes associated to bortezomib in multiple myeloma patients
    Zangari, M.
    Yaccoby, S.
    Suva, L. J.
    Dilley, J. D.
    Cavallo, F.
    Burns, M. J.
    Esseltine, D. L.
    Myers, M. T.
    Tricot, G. J. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 259 - 259
  • [28] The effect of bortezomib monotherapy and bortezomib-based regimens on bone metabolism in patients with relapsed/refractory multiple myeloma
    Terpos, E.
    Heath, D. J.
    Zervas, K.
    Anagnostopoulos, A.
    Katodritou, E.
    Christoulas, D.
    Pouli, A.
    Chantry, A.
    Anargyrou, K.
    Kastritis, E.
    Verrou, E.
    Tsionos, K.
    Croucher, P.
    Dimopoulus, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 133 - 134
  • [29] Overcoming bortezomib resistance in multiple myeloma
    Murray, Megan Y.
    Auger, Martin J.
    Bowles, Kristian M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 804 - 808
  • [30] Bortezomib dosing in relapsed multiple myeloma
    Jagannath, Sundar
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (02): : 101 - 102
12345